Inhibition of DNMT1 methyltransferase activity via glucose-regulated O-GlcNAcylation alters the epigenome

Elife. 2023 Jul 20:12:e85595. doi: 10.7554/eLife.85595.

Abstract

The DNA methyltransferase activity of DNMT1 is vital for genomic maintenance of DNA methylation. We report here that DNMT1 function is regulated by O-GlcNAcylation, a protein modification that is sensitive to glucose levels, and that elevated O-GlcNAcylation of DNMT1 from high glucose environment leads to alterations to the epigenome. Using mass spectrometry and complementary alanine mutation experiments, we identified S878 as the major residue that is O-GlcNAcylated on human DNMT1. Functional studies in human and mouse cells further revealed that O-GlcNAcylation of DNMT1-S878 results in an inhibition of methyltransferase activity, resulting in a general loss of DNA methylation that preferentially occurs at partially methylated domains (PMDs). This loss of methylation corresponds with an increase in DNA damage and apoptosis. These results establish O-GlcNAcylation of DNMT1 as a mechanism through which the epigenome is regulated by glucose metabolism and implicates a role for glycosylation of DNMT1 in metabolic diseases characterized by hyperglycemia.

Keywords: O-GlcNAcylation; chromosomes; epigenetics; gene expression; human; hyperglycemia; metabolism; mus musculus.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • DNA (Cytosine-5-)-Methyltransferase 1 / genetics
  • DNA Methylation
  • Epigenome
  • Glucose* / pharmacology
  • Glycosylation
  • Humans
  • Hyperglycemia*
  • Mice

Substances

  • Glucose
  • DNA (Cytosine-5-)-Methyltransferase 1

Associated data

  • GEO/GSE201470
  • GEO/GSE70091
  • GEO/GSE49994